Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series
In this report, we present three cases of refractory isolated non-infectious uveitis successfully treated with JAK-i. This is the first report on the use of baricitinib and upadacitinib in this context. Our findings suggest that alternative use of JAK-i, apart from tofacitinib alone, may be an effective treatment option for such patients.
Authors
- Nataša Vidović Valentinčič (ORCID: https://orcid.org/0000-0003-4136-8242)
- Matija Tomšič (ORCID: https://orcid.org/0000-0002-3554-8397)
- Pia Klobučar (ORCID: https://orcid.org/0000-0001-7717-0946)
- Polona Jaki Mekjavič (ORCID: https://orcid.org/0000-0003-1949-4525)
- Nina Vidic Krhlikar
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
- Jožef Stefan Institute (SI)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.3389/fphar.2025.1509404
- Citations
- 1
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.71